1. Home
  2. QTTB vs WETH Comparison

QTTB vs WETH Comparison

Compare QTTB & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • WETH
  • Stock Information
  • Founded
  • QTTB 2015
  • WETH 1992
  • Country
  • QTTB United States
  • WETH China
  • Employees
  • QTTB N/A
  • WETH N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • QTTB Health Care
  • WETH
  • Exchange
  • QTTB Nasdaq
  • WETH Nasdaq
  • Market Cap
  • QTTB 23.3M
  • WETH 26.1M
  • IPO Year
  • QTTB N/A
  • WETH N/A
  • Fundamental
  • Price
  • QTTB $2.39
  • WETH $2.66
  • Analyst Decision
  • QTTB Hold
  • WETH
  • Analyst Count
  • QTTB 7
  • WETH 0
  • Target Price
  • QTTB $12.17
  • WETH N/A
  • AVG Volume (30 Days)
  • QTTB 333.2K
  • WETH 466.7K
  • Earning Date
  • QTTB 11-07-2025
  • WETH 11-14-2025
  • Dividend Yield
  • QTTB N/A
  • WETH N/A
  • EPS Growth
  • QTTB N/A
  • WETH 63.71
  • EPS
  • QTTB N/A
  • WETH 0.63
  • Revenue
  • QTTB N/A
  • WETH $42,877,572.00
  • Revenue This Year
  • QTTB N/A
  • WETH N/A
  • Revenue Next Year
  • QTTB N/A
  • WETH N/A
  • P/E Ratio
  • QTTB N/A
  • WETH $4.21
  • Revenue Growth
  • QTTB N/A
  • WETH 5.58
  • 52 Week Low
  • QTTB $1.35
  • WETH $0.76
  • 52 Week High
  • QTTB $51.26
  • WETH $3.68
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 42.98
  • WETH 60.75
  • Support Level
  • QTTB $2.50
  • WETH $2.12
  • Resistance Level
  • QTTB $2.88
  • WETH $3.68
  • Average True Range (ATR)
  • QTTB 0.32
  • WETH 0.47
  • MACD
  • QTTB -0.12
  • WETH 0.00
  • Stochastic Oscillator
  • QTTB 7.28
  • WETH 53.42

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

Share on Social Networks: